J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M500188-JLR200 on August 1, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M500188-JLR200v1
46/10/2254    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norris, A. J.
Right arrow Articles by Faull, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norris, A. J.
Right arrow Articles by Faull, K. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 46, 2254-2264, October 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

A novel mass spectrometric assay for the cerebroside sulfate activator protein (saposin B) and arylsulfatase A

Andrew J. Norris1,*,{dagger}, Julian P. Whitelegge*, Arman Yaghoubian*, Jean-Rene Alattia§, Gilbert G. Privé§, Tatsushi Toyokuni**, Hubert Sun*, Mai N. Brooks{dagger}, Luigi Panza{dagger}{dagger}, Pamela Matto§§, Federica Compostella§§, Natascha Remmel***, Ralf Klingenstein***, Konrad Sandhoff***, Claire Fluharty{dagger}{dagger}{dagger}, Arvan Fluharty{dagger}{dagger}{dagger} and Kym F. Faull*

* Pasarow Mass Spectrometry Laboratory, Departments of Psychiatry & Biobehavioral Sciences and Chemistry & Biochemistry, and Neuropsychiatric Institute, University of California Los Angeles, Los Angeles, CA 90024
{dagger}{dagger}{dagger} Mental Retardation Research Center, University of California Los Angeles, Los Angeles, CA 90024
** Department of Molecular & Medical Pharmacology, University of California Los Angeles, Los Angeles, CA 90024
{dagger} Johnson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90024
§ Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, Toronto, M5G 2M9 Canada
{dagger}{dagger} Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche, e Farmacologiche, Università del Piemonte Orientale, 28100 Novara, Italy
§§ Dipartimento di Chimica, Biochimica e Biotecnologie per la Medicina, Università di Milano, 20133 Milano, Italy
*** Kekule Institut fur Organische Chemie und Biochemie, Rheinische Friedrich-Wilhelms-Universitaet Bonn, 53121 Bonn, Germany

Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500188-JLR200

1 To whom correspondence should be addressed. e-mail: anorris{at}mednet.ucla.edu

A mass spectrometric method is described for monitoring cerebrosides in the presence of excess concentrations of alkali metal salts. This method has been adapted for use in the assay of arylsulfatase A (ASA) and the cerebroside sulfate activator protein (CSAct or saposin B). Detection of the neutral glycosphingolipid cerebroside product was achieved via enhancement of ionization efficiency in the presence of lithium ions. Assay samples were extracted into the chloroform phase as for the existing assays, dried, and diluted in methanol-chloroform-containing lithium chloride. Samples were analyzed by electrospray ionization mass spectrometry with a triple quadrupole mass spectrometer in the multiple reaction monitoring tandem mass spectrometric mode. The assay has been used to demonstrate several previously unknown or ambiguous aspects of the coupled ASA/CSAct reaction, including an absolute in vitro preference for CSAct over the other saposins (A, C, and D) and a preference for the nonhydroxylated species of the sulfatide substrate over the corresponding hydroxylated species.

The modified assay for the coupled ASA/CSAct reaction could find applicability in settings in which the assay could not be performed previously because of the need for radiolabeled substrate, which is now not required.

Abbreviations: ASA, arylsulfatase A; CSAct, cerebroside sulfate activator protein; ESI, electrospray ionization mass spectrometry; IS, internal standard; MALDI, matrix-assisted laser desorption ionization; MLD, metachromatic leukodystrophy; MRM, multiple reaction monitoring; MS/MS, tandem mass spectrometry; TOF, time-of-flight; U, unit of enzyme activity (the amount of enzyme activity that will catalyze the transformation of 1 µmol of the substrate per minute under standard conditions); UCLA, University of California Los Angeles

Supplementary key words saposins A, B, C, and D • electrospray ionization • tandem mass spectrometry


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
V. E. Ahn, P. Leyko, J.-R. Alattia, L. Chen, and G. G. Prive
Crystal structures of saposins A and C
Protein Sci., August 1, 2006; 15(8): 1849 - 1857.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.